Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

VRC CHKVLP059 00 VP

Next Previous
Search
Drug Profile

VRC CHKVLP059 00 VP

Alternative Names: Alum-adjuvanted chikungunya virus-like particle vaccine; Chikungunya virus virus-like particle vaccine; Chikungunya-virus-vaccine-VRC; CHIKV-VLP; PXVX 0317; VIMKUNYA; VRC-CHKVLP059-00-VP

Latest Information Update: 24 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator National Institute of Allergy and Infectious Diseases
  • Developer Bavarian Nordic; Emergent BioSolutions; National Institute of Allergy and Infectious Diseases
  • Class Viral vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Chikungunya virus infections

Most Recent Events

  • 16 Apr 2025 VRC CHKVLP059 00 VP receives recommendation from U.S. CDC’s Advisory Committee on Immunization Practices for the prevention of disease caused by chikungunya virus
  • 07 Mar 2025 Bavarian Nordic expects approval for Chikungunya virus infections in United Kingdom (In adolescents, In the elderly, In adults, Prevention) in the first half of 2025
  • 07 Mar 2025 MHRA accepts MAA for VRC CHKVLP059 00 VP for Chikungunya virus infections (In adolescents, In the elderly, In adults, Prevention) for review

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top